Department of Oral Cell Biology, Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam, The Netherlands.
Rheumatology (Oxford). 2011 Mar;50(3):463-72. doi: 10.1093/rheumatology/keq305. Epub 2010 Nov 12.
To investigate whether maintaining the chondrocyte's native pericellular matrix prevents collagen-induced up-regulation of collagenase-3 (MMP-13) and whether integrin α1 (ITGα1) and/or discoidin domain receptor 2 (DDR2) modulate MMP-13 expression and which signalling pathway plays a role in collagen-stimulated MMP-13 expression.
Goat articular chondrocytes and chondrons were cultured on collagen coatings. Small interfering RNA (siRNA) oligonucleotides targeted against ITGα1 and DDR2 were transfected into primary chondrocytes. Chemical inhibitors for mitogen-activated protein kinase kinase (MEK1) (PD98059), focal adhesion kinase (FAK) (FAK inhibitor 14), mitogen-activated protein kinase 8 (JNK) (SP600125) and protein kinase C (PKC) (PKC412), and a calcium chelator (BAPTA-AM) were used in cell cultures. Real-time PCR was performed to examine gene expression levels of MMP-13, ITGα1 and DDR2 and collagenolytic activity was determined by measuring the amount of hydroxyproline released in the culture medium.
Maintaining the chondrocyte's native pericellular matrix prevented MMP-13 up-regulation and collagenolytic activity when the cells were cultured on a collagen coating. Silencing of ITGα1 and DDR2 reduced MMP-13 gene expression and collagenolytic activity by primary chondrocytes cultured on collagen. Incubation with the PKC inhibitor strongly reduced MMP-13 gene expression levels. Gene expression levels of MMP-13 were also decreased by chondrocytes incubated with the MEK, FAK or JNK inhibitor.
Maintaining the native pericellular matrix of chondrocytes prevents collagen-induced up-regulation of MMP-13. Both ITGα1 and DDR2 modulate MMP-13 expression after direct contact between chondrocytes and collagen. PKC, FAK, MEK and JNK are involved in collagen-stimulated expression of MMP-13.
研究维持软骨细胞固有细胞外基质是否能防止胶原诱导的胶原酶-3(MMP-13)上调,以及整合素α1(ITGα1)和/或盘状结构域受体 2(DDR2)是否调节 MMP-13 表达,以及哪种信号通路在胶原刺激 MMP-13 表达中起作用。
将山羊关节软骨细胞和软骨小体培养在胶原涂层上。针对 ITGα1 和 DDR2 的小干扰 RNA(siRNA)寡核苷酸被转染到原代软骨细胞中。使用丝裂原激活蛋白激酶激酶(MEK1)(PD98059)、粘着斑激酶(FAK)(FAK 抑制剂 14)、丝裂原激活蛋白激酶 8(JNK)(SP600125)和蛋白激酶 C(PKC)(PKC412)的化学抑制剂以及钙螯合剂(BAPTA-AM)处理细胞培养物。通过实时 PCR 检测 MMP-13、ITGα1 和 DDR2 的基因表达水平,并通过测量培养基中羟脯氨酸的释放量来测定胶原酶活性。
当细胞在胶原涂层上培养时,维持软骨细胞固有细胞外基质可防止 MMP-13 上调和胶原酶活性。在胶原上培养的原代软骨细胞沉默 ITGα1 和 DDR2 可降低 MMP-13 基因表达和胶原酶活性。PKC 抑制剂孵育可强烈降低 MMP-13 基因表达水平。用 MEK、FAK 或 JNK 抑制剂孵育的软骨细胞,其 MMP-13 基因表达水平也降低。
维持软骨细胞的固有细胞外基质可防止胶原诱导的 MMP-13 上调。ITGα1 和 DDR2 在软骨细胞与胶原直接接触后调节 MMP-13 表达。PKC、FAK、MEK 和 JNK 参与胶原刺激的 MMP-13 表达。